locyte, and natural killer (NK) lineages in mice and humans, and absent from B and T lymphocytes (16, 17) . Recently, it was discovered that MAb to Mac-1 selectively block the complement receptor type three (CRs) on mouse and human macrophages and granulocytes (18) . Anti-Mac-1 has no effect on macrophage Fc receptors or the complement receptor type one (CR 0, suggesting that Mac-1 is identical to or functionally associated with the adhesiveness of the CRs. In an interesting resemblance to CTL adhesion, adhesion through the CR3 but not the CR1 or Fc receptor is Mg+2-dependent (19, 20) . The CR3 is a physiologically important receptor on" myeloid cells that is specific for the complement component C3bi or possibly its further degradation product C3d,g (a2D) (21) . It mediates adherence to cells or particles opsonized through either the classical or alternative complement pathways with C3bi or C3d,g (22, 23) . On activated macrophages, the CR3 mediates phagocytosis (24, 25) .
LFA-1 and Mac-1 appear very similar in overall structure. They contain asubunits of Mr 180,000 or 170,000, respectively, and 13-subunits of Mr 95,000. Both subunits are glycosylated and have surface exposure (15) . In both antigens, the subunits are noncovalently associated in al/31-complexes (14, 15) . Tyrosyl tryptic peptide mapping of purified antigens has shown that the 13-subunits are very similar or identical, but the a subunits differ considerably (14) . An antigen probably identical to LFA-1 was also shown to be related to Mac-1 by peptide mapping and MAb cross-reactivity (26) . However, the peptide-mapping results should be interpreted with caution. Only the small proportion of peptides that contain tyrosine has thus far been mapped, and mapping is sensitive to a single amino acid change per peptide. Therefore, important homologies between the a-subunits as well as differences between the 13-subunits might have been missed.
The MAb to LFA-1 that were selected for blockade of CTL-mediated killing (9, 27) , and the MAb to Mac-1 that block CR3 function (16, 18) , do not crossreact (6, 14) . LFA-1 and Mac-1 also bear shared antigenic epitopes, as shown both with cross-reactive MAb selected by immunoprecipitation (6, 26) , and with conventional antisera (14) . Whether the distinct and common epitopes are present on the a-or/3-subunits has not been known.
Here, comparative studies have been carried out on these cell interaction molecules and their active sites. The degree of immunological cross-reactivity between the subunits of the LFA-1 and Mac-1 molecules is an important measure of their structural relationship. Therefore, conventional antisera have been raised to the purified Mac-1 and LFA-1 antigens and to the LFA-1 a-subunit, which recognize a broad range of antigenic epitopes, and have been used to test subunit crossreactivity. A panel of noncross-reactive MAb, as well as a newly obtained crossreactive MAb, have also been used to localize the distinct and shared epitopes to specific subunits. Both types of antibodies show that the asubunits bear the noncross-reactive or "distinct" epitopes, whereas the/3-subunits bear the common epitopes and are immunologically identical. Further, the specificity of MAb for particular epitopes on the a-and /3-subunits has been correlated with their effect on T lymphocyte-mediated killing and macrophage complement receptor activity. Functional sites have been localized to the vicinity of epitopes on the a-subunits.
Materials and Methods
Antibodies. Monoclonal antibodies (MAb) recognizing unique determinants on the LFA-1 molecule were produced by the hybridomas M7/14 (9) , M17/4, M17/5, and M17/7 (27) ; those specific for Mac-1 were obtained from the hybridomas M1/70 (16) , M19/23 and M19/24. The latter M19 hybridomas were obtained by immunization of rats with Corynebacterium parvum macrophages and selection of hybrids for macrophage specificity using standard procedures (9, 28) . The anti-/3-chain M 18/2 MAb (IgG2aK) was obtained by immunization of a rat with mouse CTL glycoproteins purified on lentil-lectin columns (29) , followed by fusion of spleen cells with the mouse myeloma P3 x 63Ag8.6.5.3 cell line (28) . The M 18/2 hybrid was selected by immunoprecipitation of LFA-1. Hybridoma lines were stabilized by subcloning. Lines grown in RPMI 1640 medium + 10% FCS secreted 50-200 #g/ml of MAb and culture supernatants were used either directly or after purification of MAb Ig as described (17) .
Polycional rat antisera to homogenous preparations of purified LFA-1 and Mac-1 antigens (15) were raised by intramuscular injection of 1 ml per rat of an emulsion in complete Freund's adjuvant containing 10 #g of purified antigen. The rats were boosted subcutaneously after 2 wk and 1 mo with 10 #g of antigen in incomplete Freund's adjuvant. An antiserum to the a-subunit of LFA-1, separated by preparative SDS-PAGE (30), was obtained by three different injections of ground and emulsified slices of gel containing the equivalent of 5 #g of LFA-1 a-subunit per boost.
Purification of Mac-1 and LFA-I. Mac-1 and LFA-1 were purified from P388D1 or EL-4 lysates on MAb-Sepharose-CL 4B columns (15) with the following modifications. The final elutions for the anti-LFA-1 M17/4 or M17/7 MAb columns were with 20 mM triethylamine, 0.1% TX-100, 1 mM PMSF, pH 11.0, and the M 17/7-Sepharose column was additionally eluted with 50 mM triethylamine, 0.5 M NaCI, 0.1% TX-100, 1 mM PMSF pH 11.5. Aliquots of fractions were analyzed by SDS-PAGE and Coomassie Blue staining as described (15) .
Iodination, lmmunoprecipitation, and Electrophoresis of Cell Membrane Proteins. Hypaque-
Ficoll purified C57BL/6J anti-P815 CTL (2 X 107 cells, viability >90%) and 4-d thioglycollate-induced peritoneal exudate cell macrophages (PEC) (2 X 107 cells, viability >95%) were iodinated using chloroglycoluril (IODO-GEN, Pierce Chemical Co., Rockford, IL) (31) .
Purified LFA-1 and Mac-1 antigens, and LFA-1 ~-and ~-subunits were iodinated in solution using chloroglycoluril (31) . Immunoprecipitation was performed in two steps. The MAb and polyclonal antisera were mixed with labeled cell lysates or purified antigens for 2 h at 4°C, followed by the addition of 40 #l of purified RG7/7.6 mouse anti-rat kappa chain coupled to Sepharose (2 mg/ml) (32) . After shaking for 1½ h at 4°C, samples were washed and subjected to SDS-PAGE (16) and autoradiography with enhancing screens (33 CTL Generation and Assay. Generation of effector cells and inhibition of mouse CTLmediated cytolysis using C57BL/6J anti-P815 (ailogeneic) and C57BL/6J anti-rat BNL4~ (xenogeneic) effector cells were performed and percentages of specific 5~Cr release and inhibition of killing activity were calculated as described (5, 27) . CR3 Rosette Analysis. The rosetting assays were performed essentially as described by Opsonization of SRBC was carried out as previously described (18) , except that the anti-Forssman antigen M1/87.27 IgM MAb (35) was used at the maximal nonagglutinating concentration of 1:32 to sensitize a 2% suspension of washed SRBC. C5-deficient A/ J mouse serum was used as the complement source.
Results

Distinct and Common Epitopes on the LFA-I and Mac-1 Molecules. A panel of 9
MAb and 3 conventional antisera were tested for cross-reactivity by immunoprecipitation of LFA-1 and Mac-1 from lysates of 125I-labeled cytolytic T lymphocytes and macrophages, respectively ( Fig. 1 ). Four independent MAb to LFA-1 obtained by selection for blockade of CTL-mediated killing precipitated LFA-1 from CTL ( Fig. 1 A, lanes 2-5), but nothing from macrophages ( Fig. 1 B , lanes 2-5). Four independent MAb to Mac-1 selected for macrophage-specificity precipitated Mac-1 from macrophages ( Fig. 1 B, lanes 7-10) , but nothing from CTL ( Fig. 1 A, lanes 7-10) . These two groups of MAb thus recognize noncrossreactive or "distinct" epitopes on the LFA-1 and Mac-1 molecules. In contrast, the M18/2 MAb precipitated LFA-1 and Mac-1 equally well ( Fig. 1A and B , lane 6). This MAb thus defines a crossreactive or "common" epitope. Conventional antisera, raised to Mac-I or LFA-1 purified by MAb affinity chromatography, were also cross-reactive ( Fig. 1A and B, lanes 12 and 13) .
Interestingly, the antibodies which recognize common epitopes precipitated an additional a-like band of 155,000 Mr from C T L and macrophage preparations ( Fig. 1 A and B , lanes 6, 12, 13) . This band is the same Mr in both cell preparations, while the Mr's of the LFA-1 and Mac-1 a-chains differ. Since it is precipitated by crossreactive but not by noncross-reactive MAb (Fig. 1 ), the 155,000 Mr band does not appear to be a degradation product. Trypsin and papain degradation products of Mac-1 are precipitated equally efficiently by crossreactive and noncrossreactive MAb (data not shown). T h e r e f o r e , this band may represent a third m e m b e r of the LFA-1 and Mac-1 family.
Another conventional antiserum was raised to LFA-1 a-chain which had been separated from LFA-1 /3-chain by preparative SDS-PAGE. Anti-LFA-1 a chain serum precipitated LFA-1 a-chain, with little or no associated 0-chain from C T L , and no Mac-1 from macrophages ( Fig. 1 C and D, lane 14) . T h e amount of LFA-1 a-chain precipitated varied from high in some preparations ( Fig. 1 E, lane 14) , to none in others (not shown), probably due to differences in the amount of achain which has become dissociated from the/3-subunit. T h e anti-LFA-1 a-chain serum appears predominantly specific for free LFA-1 a-chain as opposed to the native LFA-1 al/31-complex.
Localization of Epitopes with lmmunoblotting. T o localize epitopes to the a-or/3subunits, unlabeled subunits were separated by SDS-PAGE and transferred to nitrocellulose. Blots were probed with the rat antibodies to LFA-1 or Mac-l, then with a second l~5I-labeled anti-rat kappa chain MAb (32) . The 3-subunits of both Mac-1 and LFA-1 reacted with anti-Mac-1 serum ( Fig. 2A, lanes 2 and 5) , with anti-LFA-1 serum (Fig. 2 A, lanes 3 and 6) , and with the cross-reactive M 18/ 2 MAb (Fig. 2B, lanes 2 and 3) . This shows that common epitopes recognized by conventional antibodies and by a monoclonal antibody are present on the 3subunits. Reaction of antibodies with the 3-subunits was found after SDS-PAGE under nonreducing conditions ( Fig. 2A-C) , but not under reducing conditions (Fig. 2D ). This showed that the 3-subunits contain disulfide bonds, and that they are important for proper renaturation.
None of 8 MAb that defined specific epitopes reacted in immunoblotting, despite use of nonreducing conditions (data not shown). The anti-Mac-1 serum reacted with the Mac-1 a-chain ( Fig Localization of Specific LFA-1 Epitopes to the a-Subunit. The subunit reactivity of MAb which bind to noncross-reactive epitopes on LFA-1 was studied with two different anti-LFA-1 MAb coupled to Sepharose. During large scale purification, LFA-1 from EL-4 cells was absorbed to M17/4 or M17/7 MAb-Sepharose affinity columns. Upon elution of the M17/4 column with pH 11 buffer, small amounts of (a chain and large amounts of/3 appeared in early fractions (Fig. 3A,  lanes 1-2) , while a was greatly enriched in later fractions (Fig. 3A, lanes 4-6) .
Similarly, when the M 17/7 column was used, pH 11 buffer eluted largely/3 with only small amounts of a (Fig. 3B, lanes 1-8) , while pH 11.5 eluted a and/3 (Fig.  3B, lane 11) , followed in later fractions by very high ratios of a to/3 or a only (Fig. 3B, lanes 12-14) . Thus the a-chain can remain bound to the M17/4 or M17/7 MAb after /3 is dissociated from a, showing that a bears the LFA-1specific antigenic determinants. It appears that this antigenic epitope is lost after a elutes from the MAb-Sepharose column, probably due to a conformational change when the subunits become dissociated. This was shown using fractions eluted from the affinity columns and labeled with 12~I, and which were enriched for LFA-1 a-chains (Fig.  4A, lane 2) or/3-chains (Fig. 4A, lane 3) . The l~5I-labeled LFA-1 a could not be rebound by the same LFA-1 MAb with which it was purified (Fig. 4B, lane 9) , but was strongly bound by anti-LFA-1 a-serum (Fig. 4B, lane 7) . A positive control showed the anti-LFA-1 MAb precipitated the al/3~-complex from the preparation enriched for/3-chains ( Fig. 4 C, lane 9) . In contrast, the M 18/2 anti-/3 MAb precipitated large amounts of free/3 chain in addition to the al/3x-complex (Fig. 4C, lane 10) .
Epitopes on the Dissociated Mac-1 a-and ~-Subunits. The Mac-1 a-and/3-subunits remain associated after elution from anti-Mac-1 MAb-Sepharose at pH 11. To determine conditions for dissociation, purified l~SI-labeled Mac-1 was treated at various pH's for 30 min. at 0°C, neutralized, and samples were tested by 5 buffer (B, lanes 11-14) were performed by SDS-PAGE and Coomasie Blue staining. i m m u n o p r e c i p i t a t i o n with t h e a n t i s e r a a n d M A b to Mac-1. T h e results a f t e r t r e a t m e n t at p H 7.8 a n d 9 (not shown), p H 10 (Fig. 5A ), a n d p H 11 (Fig. 5B ) w e r e identical: t h e Mac-1 a-a n d / 3 -s u b u n i t s r e m a i n e d associated as s h o w n by p r e c i p i t a t i o n o f b o t h s u b u n i t s by the M 1 8 / 2 a n t i -C / M A b (Fig. 5A, B , lane 7) a n d the M 1 9 / 2 3 M a c -l -s p e c i f i c M A b ( Fig. 5 A a n d B, lane 6) . T r e a t m e n t at p H 11.5 c a u s e d dissociation o f t h e a-a n d / 3 -s u b u n i t s , as shown by p r e c i p i t a t i o n o f the 13-subunit but no a-subunit by anti-LFA-1 serum and the M 1 8 / 2 anti-B MAb (Fig.  5 C, lanes 3 and 7) . Concomitantly with dissociation, the determinant defined by the Mac-1-specific M 1 9 / 2 3 MAb was lost ( Fig. 5 C, lane 6) . T h e Mac-1 antiserum precipitated both a and B, showing that it contained two populations of antibodies, one reactive with the a-subunit and the other reactive with the B-subunit ( Fig. 5 C, lane 2) .
Non-cross-reactivity of Mac-1 and LFA-1 a-Chains. T h e conventional antisera to
Mac-1 and to LFA-1 a-chain were used to test for the presence of any shared epitopes on the Mac-1 and LFA-1 a-chains. ~25I-Mac-1 antigen that had been completely dissociated by t r e a t m e n t with p H 11.5 at 25°C as verified with the anti-B MAb (Fig. 6E, lane 9) and a-chain enriched, dissociated ~25I-LFA-1 preparations were used. Serial dilutions of antisera showed the LFA-1 a-chain was precipitated by as little as 1 / 2 5 ~1 of anti-LFA-1 a-serum (Fig. 6D, lane 4) , while up to 4 #1 gave no precipitation of the Mac-1 a-chain (Fig. 6C, lane 1) . This showed specificity for the LFA-1 a-chain was >100-fold. Conversely, 4 #1 of anti-Mac-1 serum did not precipitate LFA-1 a (Fig. 6B, lane 1) , but 1 / 1 2 5 ~1 precipitated the Mac-1 a-chain (Fig. 6A, lane 5) , showing specificity for Mac-1 a was >500-fold. In contrast, 0-chain specific antibodies in anti-Mac-1 serum precipitated Mac-1 B-chain and small amounts of B-chain present in the enriched LFA-1 a-chain preparation equivalently at a concentration range of 4/~1 to 1 / 125 #1 ( Fig. 6A and B, lanes 1-5) . T h e anti-LFA-1 a-serum did not precipitate any LFA-1 or Mac-1 B-chain, confirming it was completely specific for LFA-1 a.
T h e above experiments showed that the dissociated a-subunits were not crossreactive, while the dissociated ~-subunits were cross-reactive. It was next tested whether this also held for the a-and #-subunits in the native ad31-complex. Anti-Mac-1 serum was used, which had been raised to the ale/i-complex and reacted with the native complex as well as the dissociated a-and #-subunits. Anti-Mac-1 serum was absorbed with cells of the Mac-1 + P388D1 macrophagelike line or the LFA-1 + EL-4 T lymphoma line (15) , which had been solubilized with Triton X-100 to expose intracellular as well as extracellular portions of the Mac-1 and LFA-1 molecules. The absorbed serum was then tested for immunoprecipitation of the dissociated Mac-1 a-and #-subunits that were quantitated by scanning of autoradiograms. The anti-# activity in the serum was removed to the same extent by P388DI or EL-4 lysates (Fig. 7B ), suggesting that all 13-determinants recognized by the anti-Mac-1 serum are common to Mac-1 and LFA-1. Equivalent absorption by P388D~ and EL-4 was in agreement with previous findings that they have similar densities of Mac-1 and LFA-1, respectively (15) . P388D1 lysates but not EL-4 lysates absorbed the reactivity of the anti-Mac-1 serum with the Mac-1 a-subunit ( Fig. 7) . Mac-1 and LFA-1 remain in the native oq#rcomplex after solubilization with Triton X-100 (15) . No dissociation of the Mac-1 subunits in Triton X-100 was seen at neutral pH (cf. Fig. 5 ). Thus, it appears that the anti-Mac-1 antibodies that immunoprecipitate the dissociated a-and #-subunits were absorbed by the native al/31-complex. These results confirm the absence of common determinants on the a-chains of the native Mac-1 and LFA-1 molecules, and show the #-subunits are immunologically identical.
Differential Functional Effects of MAb to a-and 13-Epitopes. The above studies
showed that antibodies specific for Mac-1 or LFA-1 recognized epitopes on the a-subunits while cross-reactive antibodies recognized #-subunit epitopes. It was of great interest to explore whether antibodies binding to epitopes on the a-and #-subunits differed in their functional effects. Preliminary experiments utilizing immunofluorescence and binding of ~25I-labeled MAb to intact cells showed that both anti-a and anti-/3 MAb bind to cell surface epitopes, that the a-and 0-chain epitopes are topographically distinct as shown by lack of competitive inhibition, and that concentrations of MAb used in functional experiments gave saturation of binding (data not shown). Preclearing experiments confirmed that anti-/3 and the appropriate anti-a MAb bound to the same population of Mac-1 or LFA-1 molecules (not shown). Inhibitory effects were tested in two different cytolytic T lymphocyte assays employing B6 mouse killer T lymphocytes specific for antigens on allogeneic P815 mouse target cells or xenogeneic BN lymphoma rat target cells, respectively. The anti-LFA-1 a-chain MAb gave >85% of inhibition of T cell-mediated cytolysis in both the allogeneic and the xenogeneic killing systems, but the anti-0-chain M18/2 MAb had no effect (Table I ). MAb were similarly tested for inhibition of adherence of erythrocytes sensitized with IgM and complement to the complement receptor type 3 (CRy) on macrophages. The M1/70 and M19/23 MAb specific for Mac-1 gave strong inhibition of the percentage of macrophages forming rosettes with C3bi-sensitized erythrocytes ( (Table I) . The anti-/3-chain M18/2 MAb did not block CRs activity, but in contrast, enhanced the percentage of rosetting macrophages by (A) Secondary (1-1) xenogeneic C57BL/6J (B6) mouse anti-rat BNLO CTL (E:T=10:1) or primary (0-1) allogeneic anti-P815 CTL (E:T=2:I) were pretreated with an equal volume of MAb in 5t hybridoma culture supernatants for 15 rain at room temperature, then Cr-labeled target cells were added and the assay was completed. The spontaneous release of 5~Cr in wells containing the appropriate culture supernatant but with effector cells omitted was 3% and 14%, respectively. Percent of inhibition of specific 5~Cr release is expressed relative to CTL treated with culture supernatant of the inactive M 1/69 HK hybridoma which has lost its specific L chain. (B) Macrophages adherent to microtiter wells were pretreated for 10 min. at room temperature with 10% hybridoma culture supernatant. Then sheep erythrocytes coated with IgM (E-IgM) or with IgM followed by C5-deficient complement (E-IgM-C) were added and the assay was completed.
Wells with E-IgM had 0% rosettes. Percent of inhibition of rosetting is expressed relative to cultures with M I/69 HK culture supernatants.
25% (Table I) . This enhancing effect has been repeatedly demonstrated and is considerably more dramatic (up to 100%) when erythrocytes are suboptimally sensitized with complement and control rosetting is <50%. ~ As expected, MAb specific for Mac-1 or LFA-1 had no effect on CTL-mediated killing or CRsmediated adherence, respectively (Table I) .
Discussion Cell-cell adhesions are of crucial importance in the development and differentiation of higher organisms. Here, two molecules involved in adhesive interactions have been compared and their functional sites have been localized. Previously, the structural basis of the common and distinct epitopes (14, 26) on the Mac-1 and LFA-1 molecules had been unknown. The present studies show that the immunological cross-reactivity between the Mac-I and LFA-1 antigens is due to their /3-subunits. To explore the widest possible range of antigen epitopes, conventional antisera were raised to the purified Mac-1 and LFA-1 antigens. Crossreactions occurred only with the/3-subunit of the heterologous antigen, as shown by immunoblotting after SDS-PAGE and by immunoprecipitation after dissociation of subunits by high pH treatment. A cross-reactive MAb was also shown to bind to the LFA-1 and Mac-1 /3-subunits. Moreover, conventional sera had equal titer for LFA-1 and Mac-1 /3-subunits, and cell lysates containing LFA-1 were as effective as those containing Mac-1 in absorbing antibodies to the Mac-1 /3-subunit present in anti-Mac-1 serum. These results show the LFA-1 and Mac-1 /3-subunits are immunologically identical. Previous studies had shown the/3-subunits have essentially identical tyrosyl tryptic peptide maps, but differences among nontyrosyl peptides, which are normally more numerous, could not be ruled out (14, 26) . Taken together, these findings now show there is a high degree of identity between the Mac-1 and LFA-1/3-subunits, and that they could be encoded by a single gene.
The Mac-1 and LFA-1 a-subunits have been shown to bear the distinct epitopes. Despite the use of polyclonal antisera at concentrations 100-to 500fold higher than required for reaction with the homologous o~-subunits, no crossreaction between the a-subunits was found. Anti-a-chain activity of anti-Mac-1 serum was absorbed by Mac-1 + macrophage lysates but not by LFA-1 + lymphocyte lysates. Furthermore, distinct determinants recognized by MAb to LFA-1 were located on the ot-subunit as demonstrated by differential elution from MAb-Sepharose columns with dissociative high pH treatment. It can be deduced from the non-cross-reactivity of the a-subunits and the complete cross-reactivity of the /3-subunits as shown by conventional antisera, that the MAb-defined, distinct epitopes on Mac-1 are also present on the a-subunit. The non-cross-reactivity shows there are extensive differences between the a-subunits, in agreement with tyrosyl tryptic map data (14, 26) . It should be emphasized that many homologous proteins show no cross-reactivity or peptide map identities. A single amino acid substitution per peptide or determinant would generate differences. As a general rule for globular proteins, 60% sequence homology is required for cross-reaction to occur (36, 37) . In analogy to other protein families with shared subunits, e.g. the hemoglobins, immunoglobulins, and class I histocompatibility antigens, the a-chains are predicted to be homologous at the level of amino acid sequence.
MAb-defined epitopes on the LFA-1 and Mac-1 a-subunits were lost after dissociation from /3 with high pH. Conversely, the antisera prepared to SDSdenatured, purified LFA-1 a reacted with the free LFA-1 a-chain but not with the ad31-complex. A similar dependence of HLA a-chain conformation on association with the /3-2m subunit has been reported (38) . The most likely interpretation is that conformational changes occur in a after dissociation from /3, but it is also possible that all these antibodies recognize epitopes in the region of a/3-contact. A proportion of the antibodies to the Mac-1 al/31-complex were reactive with the free Mac-1 a-chain. These may be high affinity antibodies which can "capture" the dissociated a-chain in a conformation resembling the native one. Intact disulfide bonds were required for proper renaturation of/3chain epitopes after SDS-PAGE, but no dependence of/3-epitope conformation on association with the a-chain was detected.
The finding that epitopes could be localized to the a-and/3-chains raised the question of whether MAb binding to different epitopes would differ in their effects on function. Two anti-Mac-1 a MAb (M1/70 and M19/23) which compete for the same topographic determinant on the a subunit strongly inhibited CRs activity. The M 19/24 MAb which recognizes a second, topographically distinct epitope on the Mac-1 a-chain, did not show any inhibitory effect. Furthermore, binding of the M18/2 MAb to Mac-1 13-subunit did not inhibit complement receptor activity. A functionally important site has thus been localized to the vicinity of the M1/70-M19/23 epitope on the a-subunit. This may be a receptor site for binding of the C3bi ligand. In a similar fashion, three anti-LFA-1 MAb that recognize identical or closely related epitopes (27) on the asubunit gave strong inhibition of CTL-mediated killing, while the anti-/3 MAb gave no inhibition.
Functional sites on the LFA-1 molecules and Mac-1 thus both map to the vicinity of specific epitopes on the a-subunits. The findings emphasize the importance of these sites, but do not rule out the possibility that additional functional sites might be found with appropriate MAb. The simplest interpretation is that the a-subunit sites defined here function in adhesion, and that achain divergence reflects specialization for binding of distinct ligands. Mac-1 may bind C3bi, while the ligand for LFA-1 remains unidentified. A ligand for LFA-1 might normally be present on target cells, or deposited on them by CTL.
It is possible that further members of the LFA-1 and Mac-1 family exist which are specialized for binding of other ligands. The a-like chain of 155,000 Mr precipitated by anti-/3-antibodies might represent a distinct member of this family. It is of interest that a 150,000 Mr glycoprotein has been shown by MAb blocking studies and by its deficiency in Bernard Soulier syndrome to be involved in platelet adhesion to the subendothelial surface (39) .
The Mac-1 and LFA-1 antigens are selectively expressed on some ieukocytes, such as thioglycollate-elicited macrophages and lymphocytes, respectively, and are co-expressed on others, such as granulocytes and NK cells. The MAb used to define and to distinguish between these antigens have now been shown to recognize epitopes on the a-subunit, which can be thought of as "differentiation" epitopes. The LFA-1 and Mac-1 gene family appears ideally suited for studies on the regulation of gene expression during leukocyte differentiation. There are at least two a-chain genes and one B-chain gene. Biosynthesis studies have shown the mature antigens are derived from the assembly of the separate a-and /3precursors, implying the a-and B-genes are separate (40) . Cloning of the genes would allow studies on how a-genes are selectively expressed and how a-and Bexpression is coordinated. A particularly interesting system is the M 1 myelomonocytic cell line, which is Mac-l-but becomes strongly Mac-1 + after maturation to a macrophage phenotype is induced with corticosteroids or lymphokines (41) . Cloning should be facilitated by the antisera described here that react with the separated a-and B-subunits. They would be expected to bind to the nascent chains on polyribosomes, allowing isolation of specific mRNA's (42) , and to allow immunoprecipitation of in vitro translation products.
The human homologues of LFA-1 and Mac-1 have been found. Human LFA-1 is important in anti-HLA-DR and anti-HLA-A,B CTL-mediated killing and appears identical to murine LFA-1 in subunit composition and cell distribution (43) . The rat anti-mouse Mac-1 M1/70 MAb cross-reacts with human Mac-1 and locks the human CR3 (18) . The OKM1 MAb also blocks the CR3, 3 suggesting human Mac-1 and OKM1 are identical as was expected from their cell distributions (17, 44) . Recently, a MAb has been found that cross-reacts with human LFA-1 and Mac-1 (OKM1) antigens, and the epitope it recognizes has been localized on the B-subunit of both antigens, s The functional significance of this protein family and its subunit organization is emphasized by conservation in evolution.
Summary
Mouse Mac-l, a complement receptor-associated surface structure on macrophages, and LFA-1, a function-associated structure on lymphocytes, comprise a novel family of leukocyte differentiation antigens participating in adhesive cell interactions. Mac-1 and LFA-1 contain a-subunits of 170,000 and 180,000 Mr, respectively, and B-subunits of 95,000 Mr noncovalently associated in alB1 complexes. The structural relation between the a-and between the B-subunits, and the location of functionally important sites on the molecules, have been probed with antibodies. Both non-cross-reactive and cross-reactive monoclonal antibodies (MAb) and antisera prepared to the purified molecules or the LFA-1 a-subunits were used. Reactivity with individual subunits was studied by immunoprecipitation after dissociation induced by high pH treatment, or by immunoblotting after SDS-PAGE. Cross-reactive epitopes on Mac-1 and LFA-1 were found to be present on the B-subunits, which were immunologically identical. Non-crossreactive epitopes that are distinctive for Mac-1 or LFA-1 were localized to the a-subunits. MAb to LFA-1 a-subunit epitopes inhibited CTL-mediated killing. Two MAb to Mac-1 a-subunit epitopes but not a third MAb to a spatially distinct a-epitope inhibited complement receptor function. Neither function was inhibited by a MAb binding to a common B-subunit epitope. Therefore, sites of Mac-1 and LFA-1 involved in their respective adhesion-related functions, as well as distinctive structural features, have been localized to the ~-subunits.
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